The NF Preclinical Initiative (NFPI) represents one of the Children’s Tumor Foundation’s groundbreaking models of scientific collaboration.
The NFPI is aimed at accelerating proof of concept testing of potential effective repurposed drugs in NF relevant GEM models, and frontloading the clinical pipeline with new drug candidates for NF1. Launched in 2008, the NFPI is a revolutionary method dedicated to accelerating the search for NF treatments.
Currently, the NFPI joins the forces of four leading NF1 academic laboratories from Harvard University, University of California at San Francisco, Indiana University, and the Cincinnati Children’s Hospital (please see Appendix for biographies of the current members). These four labs have a successful track record in preclinical drug testing. They demonstrated in the Foundation’s previous preclinical efforts that they are able to efficiently determine which drugs work, and move the efficacious ones quickly into clinical trials with NF1 patients.
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...
Even before the onset of the COVID-19 pandemic, the United States was confronted with a number of significant policy concerns. Today, working together to solve those challenges is more imperative than ever. The Milken Institute is committed...
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle its most urgent challenges and realize its most exciting opportunities. Throughout the four-day event, our health teams curated nearly three...
Technical Update Dementia presents a pernicious gender-based health disparity in the United States, inflicting a disproportionate burden on women as both patients and caregivers. Given the rapid increase in the population of older Americans...
Nationwide protests in the summer of 2020 sparked many of the largest US corporations to pledge more than $200 billion to advance racial equity and confront the nation’s history of systemic racism. Nonprofits, government agencies, and...
This year’s report, Building a Resilient America: The New Consensus for Action, is part of The Milken Institute-Harris Poll Listening Project, now in its fifth year, which surveys socioeconomic, institutional, and political barriers to...
Employers seek to support their employees while normalizing a whole-person approach to substance use disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes...
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...